NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-062-2015-0-US-11 CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS US DIV 17/217,961 Pending
NIDCR E-047-2020-0-PCT-02 METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANS PCT PCT PCT/US2021/024647 Expired
NIAID E-131-2020-8-LB-04 Anti-Coronavirus Antibodies And Methods Of Use LB ORD 12153 Pending
NIBIB E-006-2020-0-PCT-02 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY PCT PCT COMB PCT/US2021/024512 Expired
NCI E-008-2019-0-US-05 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF US CON 17/214,436 Pending
NCI E-266-2011-0-IL-57 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 281806 Issued
NCI E-215-2018-0-US-08 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF US National Stage 17/278,625 Pending
NLM E-107-2010-2-US-32 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/208,940 Abandoned
NCI E-061-2020-0-CN-05 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CN National Stage 202180022592.5 Pending
NCI E-102-2020-0-CN-05 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CN National Stage 202180030252.7 Pending
NCI E-061-2020-0-PCT-02 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY PCT PCT PCT/US2021/023240 Expired
NCI E-102-2020-0-PCT-02 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY PCT PCT PCT/US2021/023225 Expired
NIAID E-220-2018-0-US-03 HIV-1 ENV FUSION PEPTIDE NANOPARTICLE CARRIER CONJUGATES AND THEIR USE US National Stage 17/277,694 Pending
NCI E-010-2019-0-US-03 Compositions And Methods For Modulation Of LMNA Expression US National Stage 17/277,397 Pending
NCI E-266-2011-0-JP-58 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage JP DIV 2021-043845 Issued
NIAID E-120-2001-1-CA-05 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES CA DIV 3114957 Expired
NCI E-050-2014-0-IN-19 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon IN DIV 202118011347 Pending
NCI E-205-2018-0-US-07 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES US National Stage 17/276,959 Pending
NIDDK E-101-2020-0-PCT-03 Antibacterial And Antifungal Polyketides From Environmental Amycolatopsis Spp. PCT PCT PCT/US2021/022571 Expired
NCI E-167-2017-0-HK-10 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY HK EP 62021027359.0 Pending
NCI E-205-2018-0-CN-05 Bicistronic Chimeric Antigen Receptor Constructs Targeting CD19 And CD20 CN National Stage 201980060609.9 Pending
NIAID E-270-2015-0-US-05 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES US DIV 17/202,231 11939356 Issued PDF
NCI E-205-2018-0-EP-06 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES EP National Stage 19787115.5 Pending
NCI E-265-2015-0-EP-19 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS EP DIV 21162567.8 Pending
NCI E-040-2012-0-KR-62 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2021-7007607 Pending
NCI E-205-2018-0-CA-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND
CD20 AND THEIR USES 		CA National Stage 3112584 Pending
NCI E-080-2020-0-PCT-02 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS PCT PCT PCT/US2021/021831 Expired
NCATS E-026-2016-0-EA-22 Compounds for Improving MRNA Splicing EA DIV 202190500 Issued
NCI E-143-2017-0-US-06 CONFORMATIONAL RESTRICTION OF CYANINE FLUOROPHORES IN FAR-RED AND NEAR-IR RANGE US CON 17/198,004 11707537 Issued PDF
NHLBI E-134-2017-3-US-17 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 US CON 17/195,766 Pending
NCI E-016-2019-0-US-03 Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists US National Stage 17/274,564 Pending
NIAID E-131-2020-8-VE-06 Anti-Coronavirus Antibodies And Methods Of Use VE ORD 2021-000050 Pending
NCI E-075-2020-0-PCT-02 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES PCT PCT PCT/US2021/021525 Expired
NIAID E-234-2016-1-US-04 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US DIV 17/194,834 11964010 Issued PDF
NIAID E-081-2013-4-AU-17 Prefusion RSV F Proteins And Their Use AU DIV 2021201468 Issued
NCI E-229-2014-0-US-10 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US CON 17/195,072 Pending
NIAID E-131-2020-8-AR-03 Anti-Coronavirus Antibodies And Methods Of Use AR ORD P210100595 Pending
NIAID E-531-2013-2-EP-08 Epstein-Barr Virus Vaccines EP DIV 21161239.5 Pending
NIAID E-131-2020-8-TW-05 Anti-Coronavirus Antibodies And Methods Of Use TW ORD 110108164 Pending
NIAID E-131-2020-8-PK-08 Anti-Coronavirus Antibodies And Methods Of Use PK ORD 196/2021 Pending
NIDDK E-043-2020-0-PC-01 RNA Target Enrichment or Depletion of Biological Supplies PCT PCT PCT/US2021/021147 Expired
NIDDK E-043-2020-0-US-02 RNA TARGET ENRICHMENT OR DEPLETION OF BIOLOGICAL SAMPLES US ORD 17/193,652 Pending
NHLBI E-134-2017-3-BR-19 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 BR DIV BR1220210042160 Pending
NLM E-125-2017-2-JP-05 CRYSTAL STRUCTURE OF CRISPR CPF1 JP DIV 2021-034456 Issued
NIAID E-131-2020-8-PCT-01 Anti-Coronavirus Antibodies And Methods Of Use PCT PCT COMB PCT/US2021/020843 Expired
NIAID E-052-2021-0-US-02 Engineered Influenza Neuraminidase Antigens US National Stage 17/904,157 Pending
NIAID E-131-2020-8-US-02 Anti-Coronavirus Antibodies And Methods Of Use US ORD 17/192,243 Abandoned
NIBIB E-076-2020-0-US-02 Fluorescence Scanning System For Analytical Ultracentrifugation US ORD 17/192,623 Pending
NIAID E-131-2020-8-HK-01 Anti-Coronavirus Antibodies And Methods Of Use HK EP 62023075291.2 Pending
NIAID E-052-2021-0-HK-01 Engineered Influenza Neuraminidase Antigens HK CN 62023069003.9 Pending